<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <h1 class="h1center">Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control (NQF 0075)</h1>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Name</span></td>
               <td width="30%">Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Id</span></td>
               <td width="30%"> 3f511433-9c5e-44bc-a533-a269977c0b5b</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Version number</span></td>
               <td width="30%">1</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Set Id</span></td>
               <td width="30%"> 35d0927e-bc5f-4a76-b168-4813411fce36</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Available Date</span></td>
               <td width="30%"> No information </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td>January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed by</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary
                  artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1- November 1 of the year
                  prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the
                  year prior to the measurement year and who had a complete lipid profile performed during the measurement year and whose LDL-C
                  was &lt; 100 mg/dL.
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3"><pre>&copy; National Committee for Quality Assurance. All Rights Reserved</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Data Aggregation</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3"><pre>This measure evaluates the percentage of patients in a specific age demographic who had a diagnosis of IVD and demonstrated adequate LDL cholesterol management. IVD and related conditions had an estimated cost burden of $393.5 billion in 2005 (AHA 2005). From 1988-1994 and from 1999-2002, adults 20 and older demonstrated lower age-adjusted total serum cholesterol levels (Carroll 2005), but there is significant room for improvement. Literature reviews and clinical guidelines advise that individuals with coronary artery disease can reduce their risk of subsequent morbidity and premature mortality by managing their cholesterol level through limitations on dietary fat and cholesterol, or in certain cases, through cholesterol lowering medications. A 10% decline in total cholesterol levels (population-wide) can result in a nearly 30% reduction in the incidence of CHD (CDC 2000). This measure facilitates the long-term management of LDL cholesterol levels for patients with IVD.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3"><pre>Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2001) AND Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines (2004): In highrisk persons, the recommended LDL-C goal is &lt; 100 mg/dL.
                
[1]An LDL-C goal of &lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence, especially for patients at very high risk.	

[2]If LDL-C is &gt; 100 mg/dL, an LDL-lowering drug is indicated simultaneously with lifestyle changes.

[3]If baseline LDL-C is &lt; 100 mg/dL, institution of an LDL-lowering drug to achieve an LDL-C level &lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence.

[4]If a high-risk person has high triglycerides or low HDL-C, consideration can be given to combining a fibrate or nicotinic acid with an LDL-lowering drug. When triglycerides are &gt; 200 mg/dL, non-HDLC is a secondary target of therapy, with a goal 30 mg/dL higher than the identified LDL-C goal.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement notation</span></td>
               <td width="80%" colspan="3"><pre>Higher score indicates better quality</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement duration</span></td>
               <td width="80%" colspan="3"><pre>12 month(s)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 2001 May.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Initial Patient Population(s): All patients 18 years of age and older during the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator(s): Patients in the initial population with an active diagnosis of ischemic vascular disease (IVD) during the measurement period or in the 12 months prior to the measurement period, or who have been discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) on or between January 1 and November 1 of the year prior to the measurement year</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exclusions: N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Numerator(s): 
N1: The number of patients who have had a low density lipoprotein cholesterol (LDL)-C test performed during the measurement period
N2: The number of patients with a LDL-C level &lt; 100 mg/dL during the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exceptions: N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3"><pre>The measure expects an LDL test result (Numerator 1) and an LDL value &lt; 100 mg/dL (Numerator 2).</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3"><pre>Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".</pre></td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d95521e351">Population criteria</a></li>
         <li><a href="#d95521e1380">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d95521e1663">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d95521e351" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic: birth date"  &gt;= 17 year(s) starts before start of "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Procedure, Performed: PTCA"  &gt;= 14 month(s) starts before or during "Measurement end date"</li>
                        <li>OR: "Procedure, Performed: PTCA"  &lt;= 24 month(s) starts before or during "Measurement end date"</li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Diagnosis, Active: acute myocardial infarction" during 
                                 <ul>
                                    <li>AND: "Encounter: Encounter acute inpt"  &gt;= 14 month(s) starts before or during "Measurement end date"</li>
                                    <li>AND: "Encounter: Encounter acute inpt"  &lt;= 24 month(s) starts before or during "Measurement end date"</li>
                                 </ul>
                                 
                              </li>
                              <li>AND: "Encounter: Encounter acute inpt"  &gt;= 14 month(s) starts before or during "Measurement end date"</li>
                              <li>AND: "Encounter: Encounter acute inpt"  &lt;= 24 month(s) starts before or during "Measurement end date"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Procedure, Performed: CABG" during 
                                 <ul>
                                    <li>AND: "Encounter: Encounter acute inpt"  &gt;= 14 month(s) starts before or during "Measurement end date"</li>
                                    <li>AND: "Encounter: Encounter acute inpt"  &lt;= 24 month(s) starts before or during "Measurement end date"</li>
                                 </ul>
                                 
                              </li>
                              <li>AND: "Encounter: Encounter acute inpt"  &gt;= 14 month(s) starts before or during "Measurement end date"</li>
                              <li>AND: "Encounter: Encounter acute inpt"  &lt;= 24 month(s) starts before or during "Measurement end date"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Diagnosis, Active: ischemic vascular disease" during ("Encounter: Encounter acute inpt"  &lt;= 2 year(s) starts before
                                 or during "Measurement end date")
                              </li>
                              <li>AND: "Encounter: Encounter acute inpt and outpt"  &lt;= 2 year(s) starts before or during "Measurement end date"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator 1 =</b>
               
               <ul>
                  <li>AND: "Laboratory Test, Result: LDL test" during "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator 2 =</b>
               
               <ul>
                  <li>AND:  MOST RECENT: "Laboratory Test, Result: LDL test (result &lt; 100 mg/dL)" during "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d95521e1380" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: acute myocardial infarction" using "acute myocardial infarction Value Set GROUPING (2.16.840.1.113883.3.464.0001.01)"
            </li>
            <li>
               "Diagnosis, Active: ischemic vascular disease" using "ischemic vascular disease Value Set GROUPING (2.16.840.1.113883.3.464.0001.84)"
            </li>
            <li>
               "Encounter: Encounter acute inpt" using "Encounter acute inpt CPT Value Set (2.16.840.1.113883.3.464.0001.43)"
            </li>
            <li>
               "Encounter: Encounter acute inpt and outpt" using "Encounter acute inpt and outpt Value Set GROUPING (2.16.840.1.113883.3.464.0001.44)"
            </li>
            <li>
               "Laboratory Test, Result: LDL test" using "LDL test Value Set GROUPING (2.16.840.1.113883.3.464.0001.89)"
            </li>
            <li>
               "Patient Characteristic: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Procedure, Performed: CABG" using "CABG Value Set GROUPING (2.16.840.1.113883.3.464.0001.22)"
            </li>
            <li>
               "Procedure, Performed: PTCA" using "PTCA Value Set GROUPING (2.16.840.1.113883.3.464.0001.110)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d95521e1663" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>"Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"</li>
            <li>"Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"</li>
            <li>"Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"</li>
            <li>"Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)"</li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure set</span></td>
               <td colspan="3">CLINICAL QUALITY MEASURE SET 2011-2012</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>